Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04826133 · ClinicalTrials.gov registry record · Early Phase 1
Vitamin D and Cocaine Administration
A Early Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT04826133 is a Early Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 4 participants.
The verdict
NCT04826133, a Early Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is designed to explore the effects of acute pre-treatment with 1,25-dihydroxyvitamin D3 (calcitriol), as compared to placebo on the behavioral (e.g., attempts to self-administer and ultimate number of infusions/boluses of cocaine self-administered), neurocognitive (e.g., performance on computerized tests of reward related learning such as the probabilistic selection task or PST and probabilistic reward task or PRT), and subjective effects (e.g, computerized visual analog scale \[VAS\] ratings of euphoria/, craving, etc.) of cocaine in experienced, non-treatment seeking users of the drug.
Interventions
- OTHER Placebo
- DRUG Calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-03-27 |
| Est. Completion | 2020-01-17 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04826133
The ClinicalTrials.gov registry entry for NCT04826133 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04826133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04826133 about?
NCT04826133 is a clinical study titled "Vitamin D and Cocaine Administration". This study is designed to explore the effects of acute pre-treatment with 1,25-dihydroxyvitamin D3 (calcitriol), as compared to placebo on the behavioral (e.g., attempts to self-administer and ultimate number of infusions/boluses of cocaine self-administered), neurocognitive (e.g., performance on co...
What is the current status of trial NCT04826133?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2019-03-27. Estimated completion is 2020-01-17.
What interventions are being tested in trial NCT04826133?
The interventions under investigation include: Placebo (OTHER), Calcitriol (DRUG).
Who is sponsoring clinical trial NCT04826133?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.